Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 153 No. 5 (2023)

Effectiveness of low-dose iron treatment in non-anaemic iron-deficient women: a prospective open-label single-arm trial

  • Stana Simic
  • Maximilian Karczewski
  • Silke Klapdor
  • Albina Nowak
  • Morton Schubert
  • Diego Moretti
  • Dorine W. Swinkels
  • Felix Beuschlein
  • Lanja Saleh
  • Paolo Suter
  • Pierre-Alexandre Krayenbuehl
DOI
https://doi.org/10.57187/smw.2023.40079
Cite this as:
Swiss Med Wkly. 2023;153:40079
Published
25.05.2023

Summary

BACKGROUND: Iron deficiency without anaemia is highly prevalent and is particularly associated with fatigue, cognitive impairment, or poor physical endurance. Standard oral iron therapy often results in intestinal irritation with associated side effects and premature discontinuation of therapy, therefore, optimal oral iron therapy with sufficient iron absorption and minimal side effects is desirable.

METHODS: Thirty-six iron-deficient non-anaemic premenopausal women (serum ferritin ≤30 ng/ml, haemoglobin ≥117 g/l) with normal body mass index (BMI) and no hypermenorrhea received 6 mg of elemental oral iron (corresponding to 18.6 mg ferrous sulphate) twice daily for 8 weeks.

RESULTS: Participants treated with low-dose iron had an average age of 28 years and a BMI of 21 kg/m2. Their serum ferritin and haemoglobin increased significantly from 18 ng/ml to 33 ng/ml (p <0.001) and from 135 g/l to 138 g/l (p = 0.014), respectively. Systolic blood pressure increased from 114 mmHg to 120 mmHg (p = 0.003). Self-reported health status improved after 8 weeks (p <0.001) and only one woman reported gastrointestinal side effects (3%).

CONCLUSION: This prospective open-label single-arm trial shows that oral iron treatment of 6 mg of elemental iron twice daily over 8 weeks is effective in iron-deficient non-anaemic women. Due to the negligible side effects, low-dose iron treatment is a valuable therapeutic option for iron-deficient non-anaemic women with normal BMI and menstruation. Further placebo-controlled studies with a larger number of participants are needed to confirm these results.

ClinicalTrials.gov NCT04636060

References

  1. Kassebaum NJ, Collaborators GA; GBD 2013 Anemia Collaborators. The Global Burden of Anemia. Hematol Oncol Clin North Am. 2016 Apr;():247–308. 10.1016/j.hoc.2015.11.002 DOI: https://doi.org/10.1016/j.hoc.2015.11.002
  2. Cogswell ME, Looker AC, Pfeiffer CM, Cook JD, Lacher DA, Beard JL, et al. Assessment of iron deficiency in US preschool children and nonpregnant females of childbearing age: National Health and Nutrition Examination Survey 2003-2006. Am J Clin Nutr. 2009 May;():1334–42. 10.3945/ajcn.2008.27151 DOI: https://doi.org/10.3945/ajcn.2008.27151
  3. Galan P, Yoon HC, Preziosi P, Viteri F, Valeix P, Fieux B, et al. Determining factors in the iron status of adult women in the SU.VI.MAX study. SUpplementation en VItamines et Minéraux AntioXydants. Eur J Clin Nutr. 1998 Jun;():383–8. 10.1038/sj.ejcn.1600561 DOI: https://doi.org/10.1038/sj.ejcn.1600561
  4. Abuaisha M, Itani H, El Masri R, Antoun J. Prevalence of Iron Deficiency (ID) without anemia in the general population presenting to primary care clinics: a cross-sectional study. Postgrad Med. 2020 Apr;():282–7. 10.1080/00325481.2020.1715701 DOI: https://doi.org/10.1080/00325481.2020.1715701
  5. Krayenbuehl PA, Battegay E, Breymann C, Furrer J, Schulthess G. Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration. Blood. 2011 Sep;():3222–7. 10.1182/blood-2011-04-346304 DOI: https://doi.org/10.1182/blood-2011-04-346304
  6. Favrat B, Balck K, Breymann C, Hedenus M, Keller T, Mezzacasa A, et al. Evaluation of a single dose of ferric carboxymaltose in fatigued, iron-deficient women—PREFER a randomized, placebo-controlled study. PLoS One. 2014 Apr;():e94217. 10.1371/journal.pone.0094217 DOI: https://doi.org/10.1371/journal.pone.0094217
  7. Verdon F, Burnand B, Stubi CL, Bonard C, Graff M, Michaud A, et al. Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial. BMJ. 2003 May;():1124. 10.1136/bmj.326.7399.1124 DOI: https://doi.org/10.1136/bmj.326.7399.1124
  8. Scott SP, Murray-Kolb LE. Iron Status Is Associated with Performance on Executive Functioning Tasks in Nonanemic Young Women. J Nutr. 2016 Jan;():30–7. 10.3945/jn.115.223586 DOI: https://doi.org/10.3945/jn.115.223586
  9. Bruner AB, Joffe A, Duggan AK, Casella JF, Brandt J. Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet. 1996 Oct;():992–6. 10.1016/S0140-6736(96)02341-0 DOI: https://doi.org/10.1016/S0140-6736(96)02341-0
  10. Hinton PS, Giordano C, Brownlie T, Haas JD. Iron supplementation improves endurance after training in iron-depleted, nonanemic women. J Appl Physiol (1985). 2000;88(3):1103-1111. DOI: https://doi.org/10.1152/jappl.2000.88.3.1103
  11. Rubeor A, Goojha C, Manning J, White J. Does Iron Supplementation Improve Performance in Iron-Deficient Nonanemic Athletes? Sports Health. 2018;():400–5. 10.1177/1941738118777488 DOI: https://doi.org/10.1177/1941738118777488
  12. Winkelman JW, Armstrong MJ, Allen RP, Chaudhuri KR, Ondo W, Trenkwalder C, et al. Practice guideline summary: Treatment of restless legs syndrome in adults: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology. 2016 Dec;():2585–93. 10.1212/WNL.0000000000003388 DOI: https://doi.org/10.1212/WNL.0000000000003388
  13. McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, et al. Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021 Dec;():4901. 10.1093/eurheartj/ehab670
  14. Milman NT. Dietary Iron Intake in Women of Reproductive Age in Europe: A Review of 49 Studies from 29 Countries in the Period 1993-2015. J Nutr Metab. 2019 Jun;:7631306. 10.1155/2019/7631306 DOI: https://doi.org/10.1155/2019/7631306
  15. Richards T, Breymann C, Brookes MJ, Lindgren S, Macdougall IC, McMahon LP, et al. Questions and answers on iron deficiency treatment selection and the use of intravenous iron in routine clinical practice. Ann Med. 2021 Dec;():274–85. 10.1080/07853890.2020.1867323 DOI: https://doi.org/10.1080/07853890.2020.1867323
  16. Snook J, Bhala N, Beales IL, Cannings D, Kightley C, Logan RP, et al. British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults. Gut. 2021 Nov;():2030–51. 10.1136/gutjnl-2021-325210 DOI: https://doi.org/10.1136/gutjnl-2021-325210
  17. Tolkien Z, Stecher L, Mander AP, Pereira DI, Powell JJ. Ferrous sulfate supplementation causes significant gastrointestinal side-effects in adults: a systematic review and meta-analysis. PLoS One. 2015 Feb;():e0117383. 10.1371/journal.pone.0117383 DOI: https://doi.org/10.1371/journal.pone.0117383
  18. Cancelo-Hidalgo MJ, Castelo-Branco C, Palacios S, Haya-Palazuelos J, Ciria-Recasens M, Manasanch J, et al. Tolerability of different oral iron supplements: a systematic review. Curr Med Res Opin. 2013 Apr;():291–303. 10.1185/03007995.2012.761599 DOI: https://doi.org/10.1185/03007995.2012.761599
  19. Ribeiro M, Fonseca L, Anjos JS, Capo-Chichi JC, Borges NA, Burrowes J, et al. Oral iron supplementation in patients with chronic kidney disease: can it be harmful to the gut microbiota? Nutr Clin Pract. 2022 Feb;():81–93. 10.1002/ncp.10662 DOI: https://doi.org/10.1002/ncp.10662
  20. Cook JD, Reddy MB. Efficacy of weekly compared with daily iron supplementation. Am J Clin Nutr. 1995 Jul;():117–20. 10.1093/ajcn/62.1.117 DOI: https://doi.org/10.1093/ajcn/62.1.117
  21. Moretti D, Goede JS, Zeder C, Jiskra M, Chatzinakou V, Tjalsma H, et al. Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood. 2015 Oct;():1981–9. 10.1182/blood-2015-05-642223 DOI: https://doi.org/10.1182/blood-2015-05-642223
  22. Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, et al.; FAIR-HF Trial Investigators. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med. 2009 Dec;():2436–48. 10.1056/NEJMoa0908355 DOI: https://doi.org/10.1056/NEJMoa0908355
  23. Rosado JL, González KE, Caamaño MC, García OP, Preciado R, Odio M. Efficacy of different strategies to treat anemia in children: a randomized clinical trial. Nutr J. 2010 Sep;():40. 10.1186/1475-2891-9-40 DOI: https://doi.org/10.1186/1475-2891-9-40
  24. Mozaffari-Khosravi H, Noori-Shadkam M, Fatehi F, Naghiaee Y. Once weekly low-dose iron supplementation effectively improved iron status in adolescent girls. Biol Trace Elem Res. 2010 Jun;():22–30. 10.1007/s12011-009-8480-0 DOI: https://doi.org/10.1007/s12011-009-8480-0
  25. Rimon E, Kagansky N, Kagansky M, Mechnick L, Mashiah T, Namir M, et al. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med. 2005 Oct;():1142–7. 10.1016/j.amjmed.2005.01.065 DOI: https://doi.org/10.1016/j.amjmed.2005.01.065
  26. Andersson M, Hurrell R, Zimmermann MB. Impact evaluation of food fortification with iron in school children and women of reproductive age. Laboratory of Human Nutrition, Institute of Food, Nutrition and Health. Vol. Doctor of Sciences. Zürich: ETH; 2010. p. 241.
  27. Kortman GA, Raffatellu M, Swinkels DW, Tjalsma H. Nutritional iron turned inside out: intestinal stress from a gut microbial perspective. FEMS Microbiol Rev. 2014 Nov;():1202–34. 10.1111/1574-6976.12086 DOI: https://doi.org/10.1111/1574-6976.12086
  28. Paganini D, Zimmermann MB. The effects of iron fortification and supplementation on the gut microbiome and diarrhea in infants and children: a review. Am J Clin Nutr. 2017 Dec; Suppl 6:1688S–93S. 10.3945/ajcn.117.156067 DOI: https://doi.org/10.3945/ajcn.117.156067
  29. Stoffel NU, El-Mallah C, Herter-Aeberli I, Bissani N, Wehbe N, Obeid O, et al. The effect of central obesity on inflammation, hepcidin, and iron metabolism in young women. Int J Obes. 2020 Jun;():1291–300. 10.1038/s41366-020-0522-x DOI: https://doi.org/10.1038/s41366-020-0522-x

Most read articles by the same author(s)